Razi Drug Research Center, Iran University of Medical Sciences, Tehran, Islamic Republic of Iran.
Department of Medicinal Chemistry, School of Pharmacy, Iran University of Medical Sciences, Tehran, Islamic Republic of Iran.
Sci Rep. 2024 Jul 28;14(1):17338. doi: 10.1038/s41598-024-68176-2.
Α-glucosidase inhibition can be useful in the management of carbohydrate-related diseases, especially type 2 diabetes mellitus. Therefore, in this study, a new series of 6-chloro-2-methoxyacridine bearing different aryl triazole derivatives were designed, synthesized, and evaluated as potent α-glucosidase inhibitors. The most potent derivative in this group was 7h bearing para-fluorine with IC values of 98.0 ± 0.3 µM compared with standard drug acarbose (IC value = 750.0 ± 10.5 μM). A kinetic study of compound 7h revealed that it is a competitive inhibitor against α-glucosidase. Molecular dynamic simulations of the most potent derivative were also executed and indicated suitable interactions with residues of the enzyme which rationalized the in vitro results.
α-葡萄糖苷酶抑制作用可用于碳水化合物相关疾病的治疗,尤其是 2 型糖尿病。因此,本研究设计、合成了一系列含不同芳基三唑取代的 6-氯-2-甲氧基吖啶衍生物,并将其作为潜在的α-葡萄糖苷酶抑制剂进行了评价。该类化合物中活性最强的是对位含氟的 7h,其 IC 值为 98.0 ± 0.3 μM,而阳性对照阿卡波糖的 IC 值为 750.0 ± 10.5 μM。化合物 7h 的动力学研究表明,它是一种竞争性的α-葡萄糖苷酶抑制剂。对最有效的衍生物进行了分子动力学模拟,结果表明它与酶残基之间存在合适的相互作用,这也解释了体外实验的结果。